← Back to search

Stipple Bio

An "epitomics" platform to define and drug cancer-specific epitopes on the cell surface

a16zActive

What they do

Problem

Cancer therapies often lack highly specific cell-surface targets, leading to limited efficacy and off-target toxicity.

Solution

Stipple Bio provides an epitomics platform to identify and enable drugging of cancer-specific cell-surface epitopes.

Who it's for

Biopharma companies and oncology drug developers seeking new cancer-specific therapeutic targets.

Company timeline

Similar startups